WHEN: FRI, oct 25 // 5:00-6:00 PM

WHERE: SEAPORT BALLROOM // MEZZANINE LEVEL (2)

Sanofi

Unlocking the Diagnostic and Prognostic Mysteries of Fabry Disease and the Role of cMRI 

*Not Available to Virtual Attendees*

Please pre-register to join Sanofi as we delve into the diagnostic and prognostic characteristics of Fabry disease. The objectives of this program are:

  • Review the natural history and pathophysiology of Fabry disease in males and females

  • Discuss the significance and clinical importance of cardiac involvement in male and female patients with Fabry disease

  • Learn how cardiac MRI-defined characteristics may result in earlier diagnosis and monitoring of this rare disease

*Pre-registration required

Speaker:

 
dr-daniele-massera-hypertrophic-cardiomyopathy

DANIELE MASSERA, MD, MSc

NYU Langone Health

 
 
 

Daniele Massera is the Associate Director of the Hypertrophic Cardiomyopathy Program at NYU Langone Health and an Assistant Professor at the NYU Grossman School of Medicine in New York. His clinical practice focuses on the evaluation and management of hypertrophic cardiomyopathy and Fabry disease. His research interests involve cardiac imaging to investigate the epidemiologic and pathophysiologic determinants of hypertrophic cardiomyopathy and calcific valve disease, as well as novel drug therapies in hypertrophic cardiomyopathy.